Literature DB >> 18448815

Oxidative stress and advanced glycation in diabetic nephropathy.

Melinda T Coughlan1, Amy L Mibus, Josephine M Forbes.   

Abstract

Nephropathy remains a significant cause of morbidity and mortality in the diabetic population and is the leading cause of end-stage renal failure in the Western World. As a result of the diabetic milieu, increased generation of reactive oxygen species (ROS) is thought to play a key role in the progression of diabetic nephropathy. Recent experimental studies have suggested that the receptor for advanced glycation end products (RAGE), which is central to the advanced glycation pathway, may mediate renal structural and functional damage via oxidative stress. This review focuses on how RAGE and subsequent ROS generation play a deleterious role in the diabetic kidney, promoting cross-talk among signaling pathways, ultimately leading to renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448815     DOI: 10.1196/annals.1433.018

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

1.  Proteomic analysis of glycated proteins from streptozotocin-induced diabetic rat kidney.

Authors:  Ashok D Chougale; Shweta P Bhat; Swapnil V Bhujbal; Mandar R Zambare; Shraddha Puntambekar; Rahul S Somani; Ramanamurthy Boppana; Ashok P Giri; Mahesh J Kulkarni
Journal:  Mol Biotechnol       Date:  2012-01       Impact factor: 2.695

2.  Extracellular Superoxide Dismutase Protects against Proteinuric Kidney Disease.

Authors:  Roderick J Tan; Dong Zhou; Liangxiang Xiao; Lili Zhou; Yingjian Li; Sheldon I Bastacky; Tim D Oury; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

3.  Inhibition of porcine kidney betaine aldehyde dehydrogenase by hydrogen peroxide.

Authors:  Jesús A Rosas-Rodríguez; Ciria G Figueroa-Soto; Elisa M Valenzuela-Soto
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

4.  Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes.

Authors:  Kamel Mohammedi; Thiago A Patente; Naïma Bellili-Muñoz; Fathi Driss; Maria Beatriz Monteiro; Ronan Roussel; Elizabeth J Pavin; Nathalie Seta; Frédéric Fumeron; Mirela J Azevedo; Luis H Canani; Samy Hadjadj; Michel Marre; Maria Lúcia Corrêa-Giannella; Gilberto Velho
Journal:  Diabetologia       Date:  2013-09-21       Impact factor: 10.122

5.  Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.

Authors:  Manuel Sanchez; Ronan Roussel; Samy Hadjadj; Abdul Moutairou; Michel Marre; Gilberto Velho; Kamel Mohammedi
Journal:  Diabetologia       Date:  2017-11-28       Impact factor: 10.122

Review 6.  Dangers within: DAMP responses to damage and cell death in kidney disease.

Authors:  Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

7.  AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.

Authors:  Weijing Cai; Massimo Torreggiani; Li Zhu; Xue Chen; John Cijiang He; Gary E Striker; Helen Vlassara
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-02       Impact factor: 4.249

Review 8.  Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.

Authors:  Daryl M Okamura; Jonathan Himmelfarb
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

Review 9.  Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

Authors:  G C Higgins; M T Coughlan
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

10.  Mitochondrial Dysfunction in Podocytes Caused by CRIF1 Deficiency Leads to Progressive Albuminuria and Glomerular Sclerosis in Mice.

Authors:  Ki Ryang Na; Jin Young Jeong; Jin Ah Shin; Yoon-Kyung Chang; Kwang-Sun Suh; Kang Wook Lee; Dae Eun Choi
Journal:  Int J Mol Sci       Date:  2021-05-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.